Other languages Diaceutics PLC

Equities

Delayed London S.E. Other stock markets 07:01:47 2024-05-23 am EDT			5-day change	1st Jan Change
127.3 ^GBX	-0.19%		+15.69%	+46.28%

May. 21	Transcript : Diaceutics PLC, 2023 Earnings Call, May 21, 2024
May. 21	Transcript : Diaceutics PLC, 2023 Earnings Call, May 21, 2024

EARNINGS AND TRADING: Topps Tiles in strategic shift as swings to loss	May. 21
Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2023	May. 21
EARNINGS AND TRADING: Michelmersh continues with positive order intake	May. 16
Diaceutics Bags Two Enterprise-wide Engagements with Large Pharmaceutical Companies	May. 16
Diaceutics plc Announces Two New Enterprise-Wide Engagements	May. 16
Roadside shares suspended; Adnams looks for funds	Apr. 02
Diaceutics upgrades diagnositc commercialisation platform, DXRX	Mar. 21
Diaceutics PLC Launches Significant Upgrade to Its DXRX Platform	Mar. 21
Sondrel wins USD23 million contract	Feb. 27
Diaceutics Expands Lab Network, Data Coverage in Europe	Feb. 27
Diaceutics announces new marketing partnership with KPMG	Feb. 14
Diaceutics maintains "momentum" for year ahead on revenue rise in 2023	Jan. 30
Diaceutics revenue grows but loss widens, CEO Keeling to step down	23-09-26
Diaceutics Announces Executive Changes	23-09-26
Diaceutics CEO to Resign; Chief Innovation Officer Named Successor	23-09-26
Earnings Flash (DXRX.L) DIACEUTICS Posts H1 Revenue GBP9.9M	23-09-26
Diaceutics PLC Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-26
Diaceutics PLC Announces Executive Changes, Effective 1 October 2023	23-09-21
Diaceutics launches daily alerts for DXRX platform	23-08-29
Diaceutics plc Launches Daily Alerts for Dxrx Platform	23-08-29

No results for this search